Visfatin: A new player in mesangial cell physiology and diabetic nephropathy

American Journal of Physiology - Renal Physiology

Volumn 295, Issue 5, 2008, Pages

  Hye, Kyoung Song ^a   Mi, Hwa Lee ^a   Bo, Kyung Kim ^a   Yun, Gyu Park ^a   Gang, Jee Ko ^a   Young, Sun Kang ^a   Jee, Young Han ^b   Sang, Youb Han ^c   Kum, Hyun Han ^c   Hyoung, Kyu Kim ^a   Cha, Dae Ryong ^a,d  

^a Korea University   (South Korea)

^b Inha University   (South Korea)

^c Inje University   (South Korea)

^d Korea University College of Medicine   (South Korea)

Author keywords

Glucose transporter 1; Glucose uptake; Profibrotic molecule; Protein kinase B

Indexed keywords

ANGIOTENSIN II; COLLAGEN; COLLAGEN TYPE 1; CYTOCHALASIN B; FK 866; GLUCOSE; GLUCOSE TRANSPORTER 1; INSULIN RECEPTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN KINASE B; SMALL INTERFERING RNA; TRANSFERASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VISFATIN;

ADIPOCYTE; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL LEVEL; CELL MEMBRANE; CELL MIGRATION; COLLAGEN SYNTHESIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETIC NEPHROPATHY; DRUG EFFECT; ENZYME ACTIVATION; FIBROSIS; GLUCOSE TRANSPORT; IMMUNOFLUORESCENCE MICROSCOPY; INTRACELLULAR SPACE; MESANGIUM CELL; NONHUMAN; NUCLEOTIDE METABOLISM; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN SECRETION; PROTEIN SYNTHESIS INHIBITION; RAT; UPREGULATION;

EID: 57349120067     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.90231.2008     Document Type: Article

References (39)

1. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 11: 327-332, 2000.
2. Ayo S, Radnik R, Garoni J, Glass W, Kreisberg J. High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am J Pathol 136: 1339-1348, 1990.
3. Ayo S, Radnik R, Garoni J, Troyer R, Kreisberg J. High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures. Am J Physiol Renal Fluid Electrolyte Physiol 261: F571-F577, 1991.
4. Ayo S, Radnik R, Glass W, Garoni J, Ranyst E, Appling D, Kreisberg J. Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high glucose medium. Am J Physiol Renal Fluid Electrolyte Physiol 260: F185-F191, 1991.
5. Axelsson J, Witasp A, Carrero JJ, Qureshi AR, Suliman ME, Heimburger O, Barany P, Lindholm B, Alvestrand A, Schalling M, Nordfors L, Stenvinkel P. Circulating levels of visfatin/pre-B-cell colony-enhancing factor-1 in relation to genotype, GFR, body composition, and survival in patients with CKD. Am J Kidney Dis 49: 237-244, 2007.
6. Berndt J, Klöting N, Kralisch S, Kovacs P, Fasshauer M, Schön MR, Stumvoll M, Blüher M. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 54: 2911-2916, 2005.
7. Brentano F, Schorr O, Ospelt C, Stanczyk J, Gay RE, Gay S, Kyburz D. Pre-B cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities. Arthritis Rheum 56: 2829-2839, 2007.
8. Chen MP, Chung FM, Chang DM, Tsai JC, Huang HF, Shin SJ, Lee YJ. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 91: 295-299, 2006.
9. Craven PA, DeRubertis FR. Protein kinase C is activated in glomeruli from streptozotocin diabetic rats: possible mediation by glucose. J Clin Invest 83: 1667-1675, 1989.
10. Dahl TB, Yndestad A, Skjelland M, Oie E, Dahl A, Michelsen A, Damas JK, Tunheim SH, Ueland T, Smith C, Bendz B, Tonstad S, Gullestad L, Froland SS, Krohg-Sorensen K, Russell D, Aukrust P, Halvorsen B. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization. Circulation 115: 972-980, 2007.
11. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in the insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986, 1993.
12. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, Watanabe E, Takagi T, Akiyoshi M, Ohtsubo T, Kihara S, Yamashita S, Makishima M, Funahashi T, Yamanaka S, Hiramatsu R, Matsuzawa Y, Shimomura I. Fat tissue produces a variety of secreted proteins (adipocytokines). Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307: 426-430, 2005.
13. Haider DG, Schaller G, Kapoiotis S, Maier C, Luger A, Wolzt M. The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia 49: 1909-1014, 2006.
14. Haider DG, Schindler K, Schaller G, Prager G, Wolzt M, Ludvik B. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab 91: 1578-1581, 2006.
15. Haneda M, Kikkawa R, Horide N, Tpgawa D, Koya N, Kajiwara N, Ooshima A, Shigeta Y. Glucose enhances type IV collagen production in cultured mesangial cells. Diabetologia 34: 198-200, 1991.
16. Hasmann M, Schemainda I. FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Res 63: 7436-7442, 2003.
17. Heilig C, Concepcion L, Riser B, Freytag S, Zhu M, Cortes P. Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics diabetic phenotype. J Clin Invest 96: 1802-1814, 1995.
18. Heilig C, Zaloga C, Lee M, Zhao X, Riser B, Brosius F, Cortes P. Immunogold localization of high affinity glucose transporter isoforms in normal rat kidney. Lab Invest 73: 674-684, 1995.
19. Hotamisligil GS, Schrgill NS, Spiegelman BM. Adipose expression of tumor necrosis factor - a direct role in obesity-linked insulin resistance. Science 259: 87-91, 1993.
20. Inoki K, Haneda M, Maeda S, Koya D, Kikkawa R. TGF-β1 stimulates glucose uptake by enhancing GLUT1 expression in mesangial cells. Kidney Int 55: 1704-1712, 1999.
21. Kikkwa R, Kajiwara N, Haneda M, Shigeta Y, Tsuda K, Yano H, Seino Y. GLUT1 is the main glucose transporter in rat mesangial cells (Abstract). J Am Soc Nephrol 3: 830, 1992.
22. Kikkawa R, Umemura K, Haneda M, Arimura T, Ebata K, Shigeta Y. Evidence for existence of polyol pathway in cultured rat mesangial cells. Diabetes 36: 240-243, 1987.
23. Kim SR, Bae SK, Choi KS, Park SY, Jun HO, Lee JY, Jang HO, Yun I, Yoon KH, Kim YJ, Yoo MA, Kim KW, Bae MK. Visfatin promotes angiogenesis by activation of extracellular signal-related kinase 1/2. Biochem Biophys Res Commun 357: 150-156, 2007.
24. Kloting N, Kloting I. Visfatin: gene expression in isolated adipocytes and sequence analysis in obese WOKW rats compared with lean control rats. Biochem Biophys Res Commun 332: 1070-1072, 2005.
25. Kreisberg JI, Radnik RA, Ayo SH, Garoni J, Saikumar P. High glucose elevates c-fos and c-jun transcripts and proteins in mesangial cells cultures. Kidney Int 46: 105-112, 1994.
26. Oki K, Yamane K, Kamei N, Nojima H, Kohno N. Circulating visfatin level is correlated with inflammation, but not with insulin resistance. Clin Endocrinol (Oxf) 67: 796-800, 2007.
27. Rea R, Donnelly R. Resistin: an adipocyte-derived hormone. Has it a role in diabetes and obesity? Diabetes Obes Metab 6: 163-170, 2004.
28. Revollo JR, Korner A, Mills KF, Satoh A, Wang T, Garten A, Dasgupta B, Sasaki Y, Wolberger C, Townsend RR, Milbrandt J, Kiess W, Imai SI. Nampt/PBEF/visfatin regulates insulin secretion in β cells as a systemic NAD biosynthetic enzyme. Cell Metab 6: 363-375, 2007.
29. Samal B, Sun Y, Stearns G, Xie C, Suggs S, McNiece I. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 14: 1431-1437, 1994.
30. Sandeep S, Velmurugan K, Deepa R, Mohan V. Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians. Metabolism 56: 565-570, 2007.
31. Sochor M, Maquer NZ, Hothersall JS, Mclean P. Effect of experimental diabetes on the activity of hexokinase isoenzymes in tissues of the rat. Biochem Int 22: 467-474, 1990.
32. Strowski MZ, Li Z, Szalkowski D, Shen X, Guan XM, Juttner S, Moller DE, Zhang BB. Small-molecule insulin mimetic reduces hyperglycemia and obesity in a nongenetic mouse model of type 2 diabetes. Endocrinology 145: 5259-5268, 2004.
33. Studer R, Craven P, DeRubertis F. Role for protein kinase C in the mediation of increased fibronectin accumulation by mesangial cells grown in high glucose medium. Diabetes 42: 118-126, 1993.
34. Takebayashi K, Suetsugu M, Wakabayashi S, Aso Y, Inukai T. Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus. Metabolism 56: 451-458, 2007.
35. Verma V, Yao-Borengasser A, Rasouli N, Bodles AM, Phanavanh B, Lee MJ, Starks T, Kern LM, Spencer HJ, McGehee RE Jr, Fried SK, Kern PA. Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation. J Clin Endocrinol Metab 92: 666-672, 2007.
36. Wakisaka M, He Q, Spiro M, Spiro R. Glucose entry into mesangial cells is mediated by both Na-coupled and facilitative glucose transporters. Diabetologia 38: 291-297, 1995.
37. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796-1808, 2003.
38. Whiteside C, Thompson J, Ohayon J. Myo-inositol and D-glucose transport in rat glomerular and cultured mesangial cells. Am J Physiol Renal Fluid Electrolyte Physiol 260: F138-F144, 1991.
39. Wolf G, Sharma K, Chen Y, Ericksen M, Ziyadeh F. High glucose-induced proliferation of mesangial cells is reversed by autocrine TGF-beta. Kidney Int 42: 647-656, 1992.